Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1554-8120

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile ; volume:27 ; number:8 ; day:22 ; month:6 ; year:2018 ; pages:1906-1928 ; date:8.2018
Medicinal chemistry research ; 27, Heft 8 (22.6.2018), 1906-1928, 8.2018

Creator: Stefanowicz, Jacek

Contributor: Słowiński, Tomasz
Wróbel, Martyna Z.
Ślifirski, Grzegorz
Dawidowski, Maciej
Stefanowicz, Zdzisława
Jastrzębska-Więsek, Magdalena
Partyka, Anna
Wesołowska, Anna
Turło, Jadwiga
SpringerLink (Online service)

DOI: 10.1007/s00044-018-2203-z

URN: urn:nbn:de:101:1-2018092222480112077414

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Stefanowicz, Jacek
Słowiński, Tomasz
Wróbel, Martyna Z.
Ślifirski, Grzegorz
Dawidowski, Maciej
Stefanowicz, Zdzisława
Jastrzębska-Więsek, Magdalena
Partyka, Anna
Wesołowska, Anna
Turło, Jadwiga
SpringerLink (Online service)

Other Objects (12)

Atypical antipsychotic agents; Peas in a pod or chalk and cheese?

Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania

2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats

Gender differences in the use of atypical antipsychotic medications for ICU delirium

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone

Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications

Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis

Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium

High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects

Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone

Atypical antipsychotic agents; Peas in a pod or chalk and cheese?

Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania

2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats

Gender differences in the use of atypical antipsychotic medications for ICU delirium

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone

Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications

Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis

Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium

High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects

Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone

Atypical antipsychotic agents; Peas in a pod or chalk and cheese?

Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania

2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats

Gender differences in the use of atypical antipsychotic medications for ICU delirium

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone

Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications

Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis

Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium

High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects

Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Atypical antipsychotic agents; Peas in a pod or chalk and cheese?

Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania

2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats

Gender differences in the use of atypical antipsychotic medications for ICU delirium

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone

Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications

Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis

Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium

High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects

Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone

Atypical antipsychotic agents; Peas in a pod or chalk and cheese?

Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania

2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats

Gender differences in the use of atypical antipsychotic medications for ICU delirium

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone

Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications

Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis

Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium

High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects

Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone

Atypical antipsychotic agents; Peas in a pod or chalk and cheese?

Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania

2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats

Gender differences in the use of atypical antipsychotic medications for ICU delirium

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone

Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications

Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis

Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium

High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects

Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone

Related objects

Reset password